'Ethical' to use experimental drugs in Ebola fight: WHO panel

August 12, 2014

A panel of medical experts has determined it is ethical to provide experimental treatments to patients infected with the deadly Ebola virus, the World Health Organization said Tuesday as the global death toll topped 1,000.

"In the particular circumstances of this outbreak, and provided certain conditions are met, the panel reached consensus that it is ethical to offer unproven interventions with as yet unknown efficacy and adverse effects, as potential treatment or prevention," the UN's health agency said in a statement.

There is currently no available cure or vaccine for Ebola, and the WHO has declared the latest outbreak a global .

But the use of an experimental drug called ZMapp on two Americans and a Spanish priest infected with the virus while working in Africa has opened up an intense ethical debate.

The drug, which is in very short supply, has reportedly shown promising results in the two Americans, but the priest has died, the Spanish hospital where he was being treated said Tuesday.

US company Mapp Bioparmaceutical which makes the drug said Monday it had sent all its available supplies to west Africa.

Medical experts from around the world took part in WHO-hosted discussions Monday to draft guidelines for using non-authorised medicines in emergencies such as Ebola.

"Ethical criteria must guide the provision of such interventions," the panel found, stressing the need for "transparency about all aspects of care, informed consent, freedom of choice, confidentiality, respect for the person, preservation of dignity and involvement of the community."

The panel of experts also emphasised the "moral obligation to collect and share all data generated, including from treatments provided for 'compassionate use'," meaning access to an unapproved drug outside of a clinical trial.

The disease has infected 1,848 people and caused 1,013 deaths since early this year, according to latest figures from the WHO, which says it is worst outbreak since Ebola was discovered four decades ago.

The has until now been limited to Guinea, Liberia, Sierra Leone and Nigeria, all countries in west Africa where ill-equipped and fragile health systems are struggling to cope.

Explore further: Eight Chinese quarantined as panic grips Ebola-hit west Africa

Related Stories

Eight Chinese quarantined as panic grips Ebola-hit west Africa

August 12, 2014
Eight Chinese medical workers who treated Ebola patients have been quarantined in Sierra Leone, as health experts grapple with ethical questions over the use of experimental drugs to combat the killer virus.

WHO meets on experimental Ebola drug use (Update)

August 11, 2014
As the world scrambles to stem the rapid spread of the killer Ebola virus, the World Health Organization hosted a meeting on Monday to discuss the ethics of using experimental drugs.

All doses of experimental Ebola drug sent to WAfrica

August 12, 2014
A US company that makes an experimental drug for treating the often deadly Ebola virus said Monday it has sent all its available supplies to West Africa.

Spanish Ebola patient gets experimental drug

August 11, 2014
Spain has imported a U.S.-made experimental Ebola drug to treat a Spanish missionary priest evacuated from Liberia last week after testing positive for the killer virus.

Spanish missionary in Liberia tests positive for Ebola

August 5, 2014
A Spanish missionary working in Liberia has tested positive for the deadly Ebola virus, the aid organisation he works for said Tuesday.

US woman with Ebola arrives in Atlanta for treatment

August 5, 2014
An American woman infected with the dangerous Ebola virus arrived at a US military base in Atlanta, Georgia, on Tuesday and is headed for treatment at a specially equipped hospital.

Recommended for you

Fresh approach to tuberculosis vaccine offers better protection

January 17, 2018
A unique platform that resulted in a promising HIV vaccine has also led to a new, highly effective vaccine against tuberculosis that is moving toward testing in humans.

Study reveals how MRSA infection compromises lymphatic function

January 17, 2018
Infections of the skin or other soft tissues with the hard-to-treat MRSA (methicillin-resistant Staphylococcus aureus) bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. ...

Newly-discovered TB blood signal provides early warning for at-risk patients

January 17, 2018
Tuberculosis can be detected in people with HIV infection via a unique blood signal before symptoms appear, according to a new study by researchers from the Crick, Imperial College London and the University of Cape Town.

New study validates clotting risk factors in chronic kidney disease

January 17, 2018
In late 2017, researchers from Boston University School of Medicine (BUSM) discovered and published (Science Translational Medicine, (9) 417, Nov 2017) a potential treatment target to prevent chronic kidney disease (CKD) ...

New study offers insights on genetic indicators of COPD risk

January 16, 2018
Researchers have discovered that genetic variations in the anatomy of the lungs could serve as indicators to help identify people who have low, but stable, lung function early in life, and those who are particularly at risk ...

Previous influenza virus exposures enhance susceptibility in another influenza pandemic

January 16, 2018
While past exposure to influenza A viruses often builds immunity to similar, and sometimes different, strains of the virus, Canadian researchers are calling for more attention to exceptions to that rule.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.